Related Articles
Characterization of mutations in BRCA1/2 and the relationship with clinic‑pathological features of breast cancer in a hereditarily high‑risk sample of chinese population
BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families
Triple‑negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia
BRCA1 and BRCA2 genetic test in high risk patients and families: counselling and management
Next‑generation sequencing of BRCA1 and BRCA2 in breast cancer patients and control subjects